About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Docs on Twitter


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Court Report | Main | USPTO News: Interim Procedures for Implementing PCT Regulation Changes »

April 01, 2007


TEVA - Your ANDA #976373 for CARVEDILOL has
received tentative approval by FDA. Can you
please advise me the date of your tentative approval? Also, I am 83 and on COREG 6.25mg
that costs me $144. for 30-day supply. Am
anxious for your generic to be marketed. When do you anticipate final FDA approval?
Do you intend to market CARVEDILOL within 75
days of approval in order to have 180 of
exclusivity? Would appreciate your reply.

I am the inventor of new drug

The comments to this entry are closed.

May 2022

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31